Vitamin K2 Market

The Vitamin K2 market is estimated to be USD 179.0 million in 2026 and is projected to reach USD 339.9 million by 2031 at a CAGR of 13.7% from 2026 to 2031. Vitamin K2 is experiencing tremendous growth, propelled by rising consumer awareness of bone, cardiovascular, and healthy aging benefits associated with Vitamin K2 supplementation. An increase in demand for pharmaceuticals, functional food and beverages, and health supplements is increasing the use of Vitamin K2 in fortified dairy products, nutraceuticals, medical nutrition, and beverages. Consumers are also switching to clean-label, naturally sourced, and scientifically supported ingredients, which is driving the use of Vitamin K2 in health and wellness products.

The growth in the Vitamin K2 market is supported by rising demand from nutraceuticals and pharmaceuticals industries globally. Vitamin K2 plays a very crucial role in bone mineralization and supports heart health by regulating calcium in the body, making it a key ingredient in functional foods, dietary supplements, and products containing Vitamin D and calcium. The increase in the number of people with osteoporosis, heart diseases, bone problems, and growth in the aging population increases the demand for Vitamin K2 products. The increase in scientific research and wider use of Vitamin K2 in fortified foods is encouraging manufacturers to expand their product offerings and production capacity.

To know about the assumptions considered for the study download the pdf brochure

Technological advancements in the market improve product quality, stability, bioavailability, and manufacturing efficiency. Manufacturers are making use of more sophisticated fermentation, purification, and use of microencapsulation technologies to develop a high-purity product of Vitamin K2 that can have higher stability and shelf life. The key players in the market include Gnosis by Lesaffre (France), Balchem Corp (US), J-OIL MILLS, INC (Japan), Novonesis A/S (Denmark), Guangdong Sungen Bioscience Co., Ltd. (China), Vesta Nutra (US), Menadiona  (Spain), GF Fermentech (South Korea), AngelYeast Co., Ltd. (China), and GeneFerm Biotechnology Co., Ltd. (Taiwan), among others.

Gnosis by Lesaffre

Gnosis by Lesaffre is a global biotechnology company specializing in scientifically validated nutritional ingredients for the human health and wellness industry, with a strong position in the Vitamin K2 market. The company's flagship MenaQ7 Vitamin K2 (MK7), produced through a natural fermentation process, is widely recognized for supporting bone and cardiovascular health and is used in dietary supplements and functional nutrition products worldwide. Leveraging Lesaffre's expertise in fermentation and biotechnology, Gnosis by Lesaffre emphasizes innovation, clinical research, quality assurance, and sustainable production while serving customers across Europe, North America, Asia Pacific, Latin America, and the Middle East & Africa through an extensive global sales and distribution network.

In March 2024, Gnosis by Lesaffre partnered with SunWay Biotech to launch MenaQ7 Metabolic, a new Vitamin K2-based solution combining its clinically validated MenaQ7 MK7 with SunWay's Ankascin 568-R red yeast rice extract. Introduced at Natural Products Expo West 2024, the formulation is designed to support cardiometabolic and cardiovascular health by promoting healthy cholesterol levels, arterial function, blood glucose management, and metabolic wellness, while addressing growing consumer demand for natural, science-backed health solutions.

Richen Nutritional Technology Co., Ltd

Richen Nutritional Technology Co., Ltd. is a China-based nutraceutical ingredient manufacturer specializing in the research, development, production, and supply of nutritional ingredients and customized nutrition solutions for the food, beverage, dietary supplement, and medical nutrition industries. In the Vitamin K2 market, the company focuses on innovation, biotechnology, and scientific research to support bone and cardiovascular health applications while offering formulation and manufacturing services to global customers. Richen operates dedicated R&D and application laboratories, collaborates with leading research institutions, adheres to internationally recognized quality management standards, and serves customers across more than 60 countries, strengthening its presence in the global Vitamin ingredients market.

In August 2023, Richen Nutritional Technology Co., Ltd. introduced a new addition to its RiviK2 series Vitamin K2 (fermented) micro-encapsulated powder. This innovative product is designed to enhance bone health by offering improved application performance and stability.

GF Fermentech Co., Ltd.

GF Fermentech Co., Ltd. is a South Korea-based biotechnology company specializing in the development, fermentation, and production of high-value functional ingredients for the nutraceutical, pharmaceutical, food, and cosmetic industries. In the Vitamin K2 market, the company leverages its microbial fermentation expertise and advanced bioprocessing capabilities to manufacture high-purity Vitamin ingredients that support bone and cardiovascular health applications. The company emphasizes continuous research and development, quality assurance, and sustainable manufacturing while serving customers across Asia, Europe, North America, and other international markets through a global distribution network.

In April 2023, GF Fermentech introduced organic nano-encapsulated Vitamin K2 MK7 products, expanding its MediQ7 range of Vitamin K2 ingredients. Sourced from Bacillus subtilis natto derived from Cheonggukjang, a Korean traditional fermented food, the Vitamin K2 ingredients focus on addressing heart, bone, kidney, and brain health. The new MediQ7 NanoEncap powder, derived from a concentration of 96% naturally fermented pure MK7, boasts a 99.9% trans-type Menaquinone 7 aligned with USP standards. These ingredients are vegan, kosher, halal, GMP, ISO 9001, and ISO 22000-certified, and are designed to offer enhanced efficacy, bioavailability, and stability.

Market Ranking

The Vitamin K2 Market is highly consolidated, where few key global manufacturers such as Gnosis by Lesaffre (France), Balchem Corp (US), J-OIL MILLS, INC (Japan), Novonesis A/S (Denmark), and Sungen Bioscience Co Ltd (China) emerge as the top competitors among a spectrum of regional vendors across various end-user industry segments. The strong hold on the industry is largely attributed to their large manufacturing facilities, wide market reach, extensive knowledge-based R&D capabilities, and comprehensive product portfolio. These companies generally offer high-quality MK7 and MK4 forms of Vitamin K2 in application specific and clinically proven manner.

The market for Vitamin K2 is continuously evolving and adapting to the increasing recognition of its role in the promotion of bone density, calcium metabolism, and heart health. Constant improvements are being made in terms of purity, stability, and bioavailability to meet regulatory standards through new production technology and sustainable raw material harvesting. The industry is also benefiting from expanding applications in dietary supplements, functional foods and beverages, pharmaceuticals, clinical nutrition, and products targeting aging populations and preventive wellness, where ongoing innovation in Vitamin K2 formulations—frequently combined with Vitamin D—is creating new growth opportunities.

At the same time, small and mid-sized Vitamin K2 producers continue to play an important role, particularly in regional markets. These companies offer flexible production capabilities, customized formulations, competitive pricing, and strong local customer support. While they may not possess the global scale and distribution networks of leading multinational players, they remain competitive by addressing niche application requirements and responding quickly to evolving customer demands.

Related Reports:

Vitamin K2 Market by Application (Health Supplements, Functional Food & Beverages, Pharmaceutical), Product Type (MK-7, MK-4), Application Form (Capsules & Tablets, Powder & Crystalline, Liquids), Source, Function, and Region – Global Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]